WETS
RMD icon

Wealth Enhancement Trust Services’s ResMed RMD Stock Holding History

Wealth Enhancement Trust Services’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$168K Buy
864
+36
+4% +$7.46K 0.02% 305
2026
Q1 		$186K Buy
828
+819
+9,100% +$204K 0.02% 289
2025
Q4 		$2.17K Buy
+9
New +$2.3K ﹤0.01% 644

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Wealth Enhancement Trust Services's RMD Position: Q2 2026 in Review

Wealth Enhancement Trust Services increased its ResMed (RMD) stake by 4.3% in Q2 2026, buying an estimated $7.46K and bringing the position to 864 shares worth $168K. The position accounts for 0.02% of the portfolio, ranked #305.

Wealth Enhancement Trust Services first reported a position in RMD in Q4 2025 and has held it in 3 quarters since. The position peaked at $186K in Q1 2026. 621 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Wealth Enhancement Trust Services held 864 shares of ResMed worth $168K as of Q2 2026.
  • Wealth Enhancement Trust Services bought 36 ResMed shares in Q2 2026, an estimated $7.46K.
  • ResMed made up 0.02% of Wealth Enhancement Trust Services's portfolio in Q2 2026, its #305 holding.
  • Wealth Enhancement Trust Services first reported a position in ResMed in Q4 2025 and has held it in 3 quarters since.
  • Wealth Enhancement Trust Services's ResMed position peaked at $186K in Q1 2026.
  • 621 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Wealth Enhancement Trust Services's 13F filing for Q2 2026, filed 15 Jul 2026.